Predictive Oncology Inc. (POAI)

Market Cap	7.77M
Revenue (ttm)	1.73M
Net Income (ttm)	-10.89M
Shares Out	8.93M
EPS (ttm)	-1.75
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	119,916
Open	0.8950
Previous Close	0.9000
Day's Range	0.8700 - 0.9200
52-Week Range	0.5500 - 3.0600
Beta	1.20
Analysts	Hold
Price Target	n/a
Earnings Date	Aug 12, 2025

About POAI

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid wa...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2002
• Employees: 24
• Stock Exchange: NASDAQ
• Ticker Symbol: POAI
• Website: https://predictive-oncology.com

Financial Performance

In 2024, Predictive Oncology's revenue was $1.62 million, a decrease of -0.24% compared to the previous year's $1.63 million. Losses were -$12.66 million, -9.44% less than in 2023.